| Literature DB >> 31320847 |
Abstract
INTRODUCTION: Systemic sclerosis (SSc) is a chronic systemic autoimmune disease of unknown aetiology. No curative therapy exists, thus management includes controlling of symptoms and prevention of complications. Ozonotherapy has multiple beneficial therapeutic effects which can translate into improving prognostic factors for SSc. AIM: To evaluate the effect of ozone on selected factors of inflammation: serum concentration of the soluble receptor of interleukin-2 (IL-2 sR), neopterin as well as the peripheral blood smear in patients with SSc.Entities:
Keywords: balneotherapy; cellular response; ozone therapy; systemic sclerosis
Year: 2019 PMID: 31320847 PMCID: PMC6627265 DOI: 10.5114/ada.2019.83651
Source DB: PubMed Journal: Postepy Dermatol Alergol ISSN: 1642-395X Impact factor: 1.837
Comparison of selected parameters before and after two series of ozone therapy
| Variable | Before ozone therapy ( | After ozone therapy ( | |||
|---|---|---|---|---|---|
| Mean ± SD | Range | Mean ± SD | Range | ||
| Concentration IL-2 sR [pg/ml] | 1563.73 ±714 | 845.0–3394 | 1249.86 ±86 | 675.1–3135.1 | 0.02 |
| Neopterin concentration [nmol/l] | 12.06 ±2.3 | 8–18.5 | 10.9 ±2.1 | 7.5–17 | 0.012 |
| Absolute monocytosis [G/l] | 1.694 ±0.640 | 0.225–4.290 | 1.480 ±0.212 | 0.168–3.120 | 0.2 |
Figure 1Correlations between the length of illness and concentration of soluble receptor IL-2 sR and neopterin before and after the treatment. A – Correlation between the length of illness and concentration of soluble receptor IL-2 sR (r = –0.12) at baseline, B – correlation between the length of illness and concentration of IL-2 sR (r = –0.05) after a series of treatments, C – correlation between the length of the illness and concentration of neopterin (r = +0.24) at baseline, D – correlation between the length of the illness and concentration of neopterin (r = +0.26) after two series of treatment
Comparison of correlations between selected parameters
| Correlation analysis | Correlation coefficient | Correlation direction and level |
|---|---|---|
| Length of illness – IL-2 sR before ozonotherapy | –0.12 | Negative, weak |
| Length of illness – IL-2 sR after ozonotherapy | –0.05 | Negative, faint |
| The length of illness – neopterin before ozonotherapy | +0.24 | Positive, weak |
| The length of illness – neopterin before ozonotherapy | +0.26 | Positive, weak |
| IL-2 sR – neopterin | +0.16 | Positive, weak |